Governance Fundamentals
The foundational knowledge that generic governance resources don't teach
Handling an Underperforming Board Member
Evaluating Licensing Deals from the Board's Perspective
CEO Evaluation in a Clinical-Stage Company
The Unwritten Rules of Effective Biopharma Boards
Everything you need to know about how high-functioning biopharma boards actually operate — the norms, habits, and expectations that governance manuals never teach you.
Why Biopharma Board Governance Is Fundamentally Different
Generic corporate governance training does not prepare you for the realities of a clinical-stage biopharma board. Here is what actually differs and why it matters.
Board Composition Strategy When You Only Have Five Seats
A large-cap board can spread expertise across twelve directors. A clinical-stage biopharma board has five, maybe seven. Every seat is a strategic decision with governance consequences.
Fiduciary Duties in a Clinical-Stage Context
What duty of care and duty of loyalty actually mean when the company has no revenue, survival depends on trial outcomes, and every major decision carries existential risk.
The First 90 Days on a Biopharma Board
A practical orientation guide for new board members joining a clinical-stage biopharma company for the first time. What to learn, who to meet, and what to focus on before your first major vote.